Reme-D

New York, NY · Founded 2022 · Privately Held (backing)

Provider of molecular diagnostic kits intended to enhance the accuracy and timeliness of disease detection. Reme-D is based in New York, NY and was founded in 2022. Its last reported valuation was $330,000 in May 2024. It has raised $520,000.

Last reported valuation
$330K
Oct 2026
Priced at
—
Total raised
$520K
Last round
—

Who backs Reme-D?

8 investors
InvestorType
TechstarsOther
Mohammed Bin Rashid Innovation FundOther
African Union Development Agency-NEPADOther
A15—
Global Innovation Fund—
Open Startup International—
TASMU Accelerator—
VISA Middleast—
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Reme-D investors

8 investors are on record for Reme-D, including Techstars, Mohammed Bin Rashid Innovation Fund, African Union Development Agency-NEPAD and A15.

Free account
More of Reme-D with a free account
  • ·Watch Reme-D: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 8 firms already write checks for companies like Reme-D. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View